Go figure: Even with that good news, the stock quickly rode down to an intraday low of $12.18 only 5 days later.
This quarter pre-post earnings…
Closing price of $11.70 on 2/20 vs. $8.39 on 2/21
Posted 11 cents per ADS, revenue of $6.3 million; analysts expected 13 cents per ADS, on revenue of $6.6 million.
2 cents below forecast + $300K revenue miss…
The “go figure” is yet to be known but today's drop did seem excessive: With the bad news, will the reverse trend from last quarter occur & we see the stock rebound?
I have no idea but as a long now suffering, I sure hope the 2 Lou’s have now gotten their wake-up call with today’s market reaction, and will be more forthright with the investment community, and will IMMEDIATELY take agressive actions to turn their stock from a “Lou-ser” into a “winner”.
Am I the only one who found it very suspicious/interesting how Roche was referenced in the conf. call today?
Will there be some form of a deal with Roche, Amgen?, one of those competitors amassing shares in SSRX?, venture groups and/or funds pursuing to their portfolio’s?, SSRX stock buyback to show confidence?
Can anyone answer my question from earlier today -- does SSRX have a poison pill established in the event of someone looking to grab them?